col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


19 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Addiction Science & Clinical Practice
  original article Date Title Authors   All Authors
1 [GO] 2026―Jan―22 Adapting opioid therapy: real-world analysis of switching from methadone to slow-release morphine and back amid COVID-19 supply chain disruptions Artūras Barkus, Emilis Subata, Haris Jakavičius, Lina Barkienė, Eglė Lydekaitė, Linas Zdanavičius, et al. (+3)
2 [GO] 2025―Mar―04 Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study Melissa Davoust, Angela R. Bazzi, Samantha Blakemore, Juliana Blodgett, Anna Cheng, Sarah Fielman, et al. (+5)
3 [GO] 2023―Oct―17 Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff Shannon Gwin Mitchell, Julia Jester, Jan Gryczynski, Melanie Whitter, Douglas Fuller, Caroline Halsted, Robert P. Schwartz
4 [GO] 2023―Sep―13 Early COVID-Related pandemic impacts and subsequent opioid outcomes among persons receiving medication for opioid use disorder: a secondary data analysis of a Type-3 hybrid trial Tim Janssen, Bryan R. Garner, Julia Yermash, Kimberly R. Yap, Sara J. Becker
5 [GO] 2023―Mar―29 “Sign Me Up”: a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic James B. Darnton, Elenore P. Bhatraju, Kristin Beima-Sofie, Alyssa Michaels, Kevin A. Hallgren, Sean Soth, et al. (+3)
6 [GO] 2023―Jan―20 Impact of the COVID-19 pandemic on burnout and perceived workplace quality among addiction treatment providers Andrea Fentem, Raven Riordan, Christine Doroshenko, Xiao Li, Erin Kasson, Devin Banks, et al. (+2)
7 [GO] 2022―Dec―15 Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy Soroush Moallef, Kora DeBeck, Nadia Fairbairn, Zishan Cui, Rupinder Brar, Dean Wilson, et al. (+3)
8 [GO] 2022―Nov―30 Risk of COVID-19 infection and the associated hospitalization, ICU admission and mortality in opioid use disorder: a systematic review and meta-analysis Amir Hossein Behnoush, Elham Bazmi, Mehdi Forouzesh, Behnam Behnoush
9 [GO] 2022―Sep―05 Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County Angela R. Bazzi, Alicia Harvey-Vera, Tara Buesig-Stamos, Daniela Abramovitz, Carlos F. Vera, Irina Artamonova, et al. (+2)
10 [GO] 2022―Apr―25 Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis Suzan M. Walters, Rebecca S. Bolinski, Ellen Almirol, Stacy Grundy, Scott Fletcher, John Schneider, et al. (+5)
11 [GO] 2022―Mar―07 Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown Jacqueline Hodges, Marika Waselewski, William Harrington, Taylor Franklin, Kelly Schorling, Jacqueline Huynh, et al. (+6)
12 [GO] 2022―Jan―29 Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study Anna Cheng, Ryan Badolato, Andrew Segoshi, Ryan McDonald, Mia Malone, Kumar Vasudevan, et al. (+7)
13 [GO] 2021―Dec―11 Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis Ximena A. Levander, Kim A. Hoffman, John W. McIlveen, Dennis McCarty, Javier Ponce Terashima, P. Todd Korthuis
14 [GO] 2021―Nov―13 Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review Noa Krawczyk, Adetayo Fawole, Jenny Yang, Babak Tofighi
15 [GO] 2021―Jul―30 Protecting patients and staff in residential treatment centers during exposure to COVID-19: commentary Kimberly A. Johnson, Carolyn Keough, Holly Hills, Wouter Vermeer, Rebecca Lengnick-Hall, Moira McNulty, et al. (+2)
16 [GO] 2021―Apr―28 Correction to: Adapting inpatient addiction medicine consult services during the COVID-19 pandemic Miriam T. H. Harris, Alyssa Peterkin, Paxton Bach, Honora Englander, Emily Lapidus, Theresa Rolley, et al. (+2)
17 [GO] 2021―Feb―24 Adapting inpatient addiction medicine consult services during the COVID-19 pandemic Miriam T. H. Harris, Alyssa Peterkin, Paxton Bach, Honora Englander, Emily Lapidus, Theresa Rolley, et al. (+2)
18 [GO] 2021―Jan―20 Multiple clinical risks for cannabis users during the COVID-19 pandemic Ellen Mello Borgonhi, Vanessa Loss Volpatto, Felipe Ornell, Francisco Diego Rabelo-da-Ponte, Felix Henrique Paim Kessler
19 [GO] 2021―Jan―07 Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model Ethan Cowan, Maria R. Khan, Siri Shastry, E. Jennifer Edelman
 [1] 

19 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec